[1]
Mohammed, Z.A. et al. 2026. Neuroimmunological Shifts in Disease-Modifying Therapy Use Among Multiple Sclerosis Patients: A Regional Study from Sulaymaniyah, Iraq. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ). 11, 2 (Nov. 2026), 293–297. DOI:https://doi.org/10.54133/ajms.v11i2.3387.